tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cautious Hold Rating on Regulus Amid Merger Uncertainties and Strategic Developments
PremiumRatingsCautious Hold Rating on Regulus Amid Merger Uncertainties and Strategic Developments
4M ago
Regulus Therapeutics to be Acquired by Novartis
Premium
Company Announcements
Regulus Therapeutics to be Acquired by Novartis
4M ago
Regulus reports Q1 EPS (15c), consensus (26c)
Premium
The Fly
Regulus reports Q1 EPS (15c), consensus (26c)
4M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
4M ago
Regulus downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Regulus downgraded to Perform from Outperform at Oppenheimer
5M ago
Regulus downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Regulus downgraded to Market Perform from Outperform at Leerink
5M ago
Regulus Announces Merger Agreement with Novartis
PremiumCompany AnnouncementsRegulus Announces Merger Agreement with Novartis
5M ago
Regulus to be acquired by Novartis for $7.00 per share in cash
Premium
The Fly
Regulus to be acquired by Novartis for $7.00 per share in cash
5M ago
Regulus to be acquired by Novartis for $7.00 per share in cash
Premium
The Fly
Regulus to be acquired by Novartis for $7.00 per share in cash
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100